CIPLA USA, INC. v. ANI PHARMACEUTICALS, INC. et al
| CIPLA USA, INC. |
| ANI PHARMACEUTICALS, INC. and NIKHIL LALWANI |
| 3:2021cv20059 |
| November 17, 2021 |
| US District Court for the District of New Jersey |
| Defend Trade Secrets Act (of 2016) |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 17, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Corporate Disclosure Statement by CIPLA USA, INC. identifying Cipla USA, Inc. as Corporate Parent.. (ABRAHAM, ERIC) |
| Filing 1 COMPLAINT against ANI PHARMACEUTICALS, INC., NIKHIL LALWANI ( Filing and Admin fee $ 402 receipt number ANJDC-12988250) with JURY DEMAND, filed by CIPLA USA, INC.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Civil Cover Sheet)(ABRAHAM, ERIC) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
